These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35121826)

  • 1. MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG.
    Xu LM; Zhang J; Ma Y; Yuan YJ; Yu H; Wang J; Cao XC; Zhu L; Wang P
    Oncogene; 2022 Mar; 41(12):1742-1751. PubMed ID: 35121826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
    Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101.
    Si W; Zhao Y; Zhou J; Zhang Q; Zhang Y
    Exp Cell Res; 2019 Jun; 379(1):1-10. PubMed ID: 30898548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
    Zhao C; Ling X; Xia Y; Yan B; Guan Q
    Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
    He J; Wang J; Li S; Li T; Chen K; Zhang S
    Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.
    Azhati B; Reheman A; Dilixiati D; Rexiati M
    Arch Biochem Biophys; 2023 Jun; 741():109604. PubMed ID: 37080415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.
    Jiang X; Chen Y; Du E; Yang K; Zhang Z; Qi S; Xu Y
    Cell Signal; 2016 Sep; 28(9):1216-1224. PubMed ID: 27267060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Al-MPS Obstructs EMT in Breast Cancer by Inhibiting Lipid Metabolism via miR-215-5p/SREBP1.
    Wu CL; Xu LL; Peng J; Zhang DH
    Endocrinology; 2022 May; 163(5):. PubMed ID: 35366327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Zhao C; Ling X; Li X; Hou X; Zhao D
    Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA 000554 represses epithelial-mesenchymal transition in breast cancer by regulating microRNA-182/ZFP36 axis.
    Mao Y; Lv M; Cao W; Liu X; Cui J; Wang Y; Wang Y; Nie G; Liu X; Wang H
    FASEB J; 2020 Sep; 34(9):11405-11420. PubMed ID: 32729957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
    Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
    Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
    Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
    [No Abstract]   [Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.